ALKINYLCHINAZOLIN-VERBINDUNGEN

Patent europeic · EP4013749 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4013749
Numer da la dumonda
EP20764505
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-08-2020
Publitgà
22-06-2022
Concedì
11-03-2026
La protecziun finescha il pli tard
13-08-2040
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
C07D 401/06 (2006.01)
C07D 401/14 (2006.01)
C07D 403/06 (2006.01)
C07D 405/06 (2006.01)
C07D 405/14 (2006.01)
C07D 413/06 (2006.01)
C07D 413/14 (2006.01)
C07D 471/04 (2006.01)
C07D 471/08 (2006.01)
C07D 487/08 (2006.01)
C07D 491/10 (2006.01)
C07D 498/08 (2006.01)
A61K 31/5377 (2006.01)
A61K 31/517 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201962887392 P 15.08.2019
US 202063065028 P 13.08.2020
Dumonda PCT
PCT/US2020/046425 14.08.2020
Publicaziun PCT
WO2021/030711 18.02.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 11-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.03.2026

Partidas

Possessur

Black Diamond Therapeutics, Inc.

245 First Street, 18th Floor, Cambridge, MA 02142, US

Inventur

LUCAS, Matthew C.

Lexington, Massachusetts 02421, US

PADILLA, Fernando

Arlington, Massachusetts 02474, US

FLOHR, Alexander

4051 Basel

ARISTA, Luca

4125 Riehen

BUCK, Elizabeth

Huntington, New York 11734, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.